mated ELISA reader (Titertek Multiscan Plus; Flow Laboratories, Inc., McLean, VA). Dosedependent binding curves for IgM, IgG, and IgA were constructed and used as references (3, 13) . IgM, IgG, and IgA to various antigens were titrated using antigen-specific ELISAs as described (3, 7, 13) . Plates were coated with 5 pg/ml of purified human IgG Fc fragment (52,000 mol wt), purified human IgG,, IgG2, IgG3, IgG¢ (Calbioehem-Behring Corp., San Diego, CA), purified F(ab`)2 fragment of human IgG, ssDNA, or purified human Tg, 1.5 pg/ml of purified TT, or 2.5 pg/ml of recombinant human Ins (a gift from Lilly Research Laboratories, Indianapolis, IN), prepared as described (3, 7, 13) . Alkaline phosphatase-con-'°' goat F(aV)2 fragments to x and X L chains (Sigma Chemical Co.) were used to detect Ig L chains . A cocktail ofthree mouse mAbs to human IgG Fab! fragment (ICN Biomedicals, Inc., Costa Mesa, CA) was used to detect IgG to IgG Fc fragment . Refer ence binding curves were constructed using antibodies to IgG Fe fragment, ssDNA, Tg, Ins, and TT (13) . The lower limit of sensitivity, corresponding to the threshold oflinear detectability, of IgM-, IgG-, and IgA-, or antigen-specific ELISAs was 5 ng Ig/ml .
Preparation ofHuman Monoclonal B CellLines and Construction ofCell Hybrids by Somatic Hybridization Techniques. Monoclonal EBVtransformed B cell lines, selected for production of IgG Fc fragment-binding antibodies, were established using sorted CD5' B cells from RA patients, as described (7) . Some of those clones were stabilized by fusion with 173136 cells, a human-mouse heterohybrid, as described (7) . The resulting EBVtransformed B cell hybrids were expanded in selection medium and sequentially cloned at 0.5 cell/well (7) . Clones were amplified and the mAbs produced separated as described (7) .
Competitive Inhibition Studies. Competitive inhibition studies of the binding of human mAb to solid-phase Fc fragment by the homologous or heterologous soluble ligands were performed as described (7) . The dissociation constants (Kd) of the mAbs for IgG Fc fragment were calculated according to Friguet et al. (15) . This method has been successfully applied to the calculation of Kd in antigen-antibody systems involving multivalent linkages (7, 16, 17) .
1981
Characterization of Peripheral Blood CD5 B Lymphocytes from Normal Subjects and Patients with RA. The percentage of CD5* B cells in the peripheral circulation of normal subjects and patients with RA was determined by dual-color fluorescence flow cytometry. Enriched peripheral blood B lymphocytes were reacted with PElabeled mAb to CD20, biotinylated mAb to CD5, subsequently stained with FITCavidin, and then applied to the FAGS for analysis. Typical contour maps derived are shown in Fig. 1 , A-H . Evaluation by this method of 28 healthy subjects and 13 patients with RA revealed that 18.0 t 4.7% (mean value t SD; range: 9.2-24.4) and 37.4 ± 10.6% (range: 22.1-54 .5) of the total B lymphocytes (CD20+ cells), respectively, were C135' .
CD20+ /CD5+ and CD20+/CD5 -lymphocytes were then investigated for their light-scattering properties and representative results are depicted in Fig. 1, I , J, M, and N. In cytofluorometric studies, the amplitudes of the forward and side light scatter signals are considered proportional to the size and the internal complexity of the cell, respectively (18) . Scatter analysis revealed that the CD5-B lymphocytes were homogeneous and small in both healthy subjects and patients. In contrast, >45 % of the CD5+ B lymphocytes from RA patients were large ( Fig. 1 N) as compared with 6% of the CD5+ B lymphocytes from healthy subjects (Fig. 1 J) . To measure spontaneous proliferation and Ig secretion, CD20+ /CD5 + and CD20+ /CD5-B lymphocytes then were sorted and collected as two separate fractions . Reanalysis of the lymphocytes sorted as CD5+ and CD5' showed that these cells fell back within the coordinates respectively established for the sorting procedure (Fig. 1, K Identification, light scattering analysis, and sorting of CD5* B cells in healthy subjects and RA patients . Data are depicted as computer-derived contourgrams obtained from the cytofluorometric analysis of enriched B lymphocytes . Countourgrams shown here are representative examples of the patterns observed for individuals of the two groups studied . Enriched B lymphocytes from healthy subjects or RA patients were reacted with : biotin-labeled IgG2a mAb and PE-labeled IgG2a mAb (both with irrelevant specificity) and then FITC-avidin (t1 and E) ; biotin-labeled mAb to CD5 (Leu-1) and then FITC-avidin (B and F) ; PE-labeled mAb to CD20 (C and G) ; biotin-labeled mAb to CD5, PE-labeled mAb to CD20, and then FITC-avidin (D and H) . Double-(red and green) fluorescent (CD20' /CD5*) cells represent CD5* B lymphocytes . These cells (right dotted rectangle), and their CD20* /CD5 -counterparts (left dotted rectangle), were sorted as CD5* and CD5 -B lymphocytes, respectively (D and H) . Contourgrams derived from the analysis of the B cells sorted as CD5 -and CD5* are depicted in K and O, and L and P, respectively. Corresponding insets contain the profiles of the relative green fluorescence intensity of these sorted cell fractions (x-axis is relative green fluorescence intensity andy-axis is relative cell number) . Forward (x-axis) and side (y-axis) light scattering analysis of CD5 -and CD5* B cells, are shown in I and M, and J and N, respectively. L, 0, and P). The sorted CD5' and CD5-B cells then were cultured without added stimulus . Neither CD5' nor CD5 -B cells from any of the healthy subjects showed significant [3H]TdR incorporation over a 6-d period (Fig. 2 A) . In contrast, CD5+ , but not CD5-, B lymphocytes from each of the patients with RA displayed a high rate of spontaneous [3H]TdR incorporation when cultured under identical conditions (Fig. 2 B) .
High rates of spontaneous RF production have been reported in culture fluids of circulating PBMC from RA patients (19) . To determine whether CD5' B cells, CD5-B cells, or both were responsible for this spontaneous Ig secretion, the amount of IgM, IgG, and IgA produced in the microcultures seeded in the above experiment ( Fig . 2 ) was determined . In healthy subjects, neither CD5' nor CD5B lymphocytes spontaneously produced significant amounts of Ig, even after 6 d of culture (Fig. 3 , A-C). In contrast, unstimulated CD5 + , but not CD5 -, B cells from patients with RA produced large amounts of IgM, IgG, and IgA ( To further investigate their antibody-producing potential, lymphocytes from 18 healthy subjects and 13 patients with RA were sorted into CD5' and CD5-fractions, infected with EBV and cultured at 1,000/well, in presence ofirradiated PBMC feeders. After 4 wk, total IgM, IgG, and IgA concentrations were measured in the supernatants of these microcultures. CD5+ B cells from RA patients produced 7,460 t 578, 162 t 43, and 66 t 16 ng/microculture (mean value t SD of 184 microcultures) of IgM, IgG, and IgA, respectively. These amounts were not significantly different from those produced by CD5 -B cell microcultures from the same subjects (5,953 t 469, 287 t 51, and 68 t 12 ng/microculture, respectively ; mean value t SD of 184 microcultures). Comparable values were obtained when the amounts of IgM, IgG, and IgA were measured in the microcultures seeded with CD5' or CD5 -B cells from healthy subjects (not shown) .
The binding activities of these Ig to TT (an exogenous antigen) and IgG Fc fragment (a self-antigen) are shown in Fig. 4 . In both normal controls and patients with RA, virtually all cells producing antibodies (IgM, IgG, and IgA) to IgG Fc fragment segregated with the CD5' B lymphocyte subset (Fig. 4 A) . Cells producing IgM antibodies to TT also segregated primarily with the CD5' B subset, but cells producing IgG and IgA antibodies to TT segregated with the CD5" B cell subset (Fig. 4 B) .
Construction ofMonoclonal Cell Linesfrom CD5' B Lymphocytes and Characterization of the mAbs they Produce. To study the fine specificity of autoantibodies to IgG Fc fragment, EBVtransformed B cell lines were generated using purified CD5' B cells from three different RA patients. After three sequential cloning steps, 18 EBV transformed B cell lines producing RF were obtained and the antigen-binding activity of the monoclonal RFs were investigated using ELISAs with a panel of selfand non-self antigens. As shown in Table I , the monoclonal RFs could be divided into two groups based on their antigen-binding reactivity. Eight mAbs (seven IgM and one IgA) were polyreactive ; they bound not only to the IgG Fc fragment, but also to the four other antigens tested . The other 10 mAbs (five IgM and five IgA) were monoreactive and bound efficiently only to IgG Fc fragment . In these experiments (Table I) Fluids from microcultures seeded with 1,000 or 2,000 EBVinfected CD5', CD5-, or unfractionated B cells were tested for the two antigen-binding activities . Each dot represents an individual microculture and -100 microcultures from each group were tested . Data were derived from two healthy subjects and two RA patients and are representative of the results consistently obtained from these groups of subjects .
In RA, cells committed to the production of monoreactive RF were about one-tenth as frequent as those committed to the production of polyreactive RE Thus far, in healthy individuals, we could not detect any circulating B cell committed to the production of monoreactive RE
The multiple antigen-binding capacities of polyreactive RFs were further documented in experiments in which each antibody was tested at different concentrations . All polyreactive RFs bound in a dose-dependent fashion, but to different respectively. The specificity of the monoreactive RFs for the IgG Fc fragment was further supported by their inability to bind to the purified F(ab')2 portion of IgG and their comparable ability to bind to the Fc fragment of different IgG subclasses (i .e ., IgG1, IgG2, IgG3, and IgG4) (not shown) .
The binding activity of polyreactive and monoreactive RFs was studied in greater depth by competitive inhibition experiments ( Figure 5 , A'-C, and D'-F') in which the binding of a given RF to solid-phase IgG Fc fragment was measured in the presence and absence of soluble homologous (i .e ., IgG Fc fragment) or heterologous antigens (i .e ., ssDNA, Tg, Ins, or TT). The binding of polyreactive RFs to solid-phase IgG Fc fragment was inhibited in a dose-dependent fashion not only by the soluble Fc fragment itself, but also, and with even higher efficiency, by some of the other soluble ligands tested (Fig . 5, A'-C') . The binding of monoreactive RFs to solidphase IgG Fc fragment also was inhibited in a dose-dependent fashion by the soluble Fc fragment, but not by any of the other soluble heterologous antigens, even at the highest concentrations tested (Fig. 5, D'-F') .
The competitive inhibition experiments enabled us to calculate the Kd of RFs for IgG Fc fragment (7, 15) . The Kd values of polyreactive RFs were in the range of 10' mollliter (Table II) 
Discussion
RFs are autoantibodies directed against determinants on the constant portion of the IgG H chain (20) . They are present at high titer in sera and synovial fluids of patients with RA and are thought, but have not been proven, to be relevant to the pathogenesis of this disease. Circulating antibodies (mainly IgM) with RRbinding activity can also be detected in healthy subjects and their titer rises in the course of viral, bacterial, and parasitic infections (21, 22) or during immune response to exogenous antigens (23) . Recent studies (3, 4, 6, 7) showed that in healthy subjects virtually all the precursors of the RRproducing B cells belong to the CD5' B cell subset . Moreover, these RFs are polyreactive and bind to a number of different self (e.g., ssDNA, Ins, Tg, etc.) and non-self (e.g., TT and bacterial LPS) antigens (6, 7) .
The present work and recent reports from other laboratories (4, 10, 11) show that the number of CD5' B cells are increased in patients with RA. In addition, we show here that many of the CD5+, but not the CD5", B cells from RA patients are activated, spontaneously proliferate, and secrete Ig with RF activity. In contrast, studies in progress (Burastero et al., in preparation.) indicate that CD5' B cells from patients with SLE are not increased in number and do not spontaneously proliferate in vitro, suggesting that different mechanisms are operative in SLE and RA. Although EBV has been suggested as a possible factor in the pathogenesis of RA (24, 25) , immunofluorescence and in situ DNA hybridization on the spontaneously proliferating CD5' cells has failed to show any evidence of EBV infection (unpublished data).
In addition to the polyreactive RFs produced by CD5' B cells, the present study shows that some CD5' B cells from RA patients produce monoreactive high affinity RFs. The dissociation constant of these monoreactive RFs is -10-1 mol/liter. In contrast, affinity values (Kav) previously reported (26) as characteristic of human RFs ranged between 103 and 105 liters/mol . This is compatible with the Kd values of our polyreactive RFs from both normal subjects (7) and patients with RA, but lower by a factor of at least 100 as compared with the monoreactive RFs from CD5' cells of RA patients . Thus, we conclude that in RA patients two types of RFs are produced: one that is polyreactive and low affinity (Kd, 10" 5 moltliter) and the other one that is monoreactive and relatively high affinity (Kd, 10" 7 mollliter). The polyreactive low affinity RFs are found in the B cell repertoire of both normal individuals and patients with RA, whereas the monoreactive high affinity RFs have been found, thus far, only in the B cell repertoire of RA patients. Along this line, it has recently been reported that two-thirds of the monoclonal autoantibodies generated from nonimmunized, viable motheaten C57BL16J autoimmune mice are polyreactive and the remaining one-third are monoreactive (9) . Polyclonal B cell activation has been proposed as a possible mechanism to account for production of autoantibodies in systemic autoimmune diseases (27, 28) . Based on this model, one would predict that the autoantibodies produced should have the functional features ofthe anti-self antibodies found in healthy subject, i.e., polyreactive and relatively low affinity for self-antigens. The present study shows that in patients with RA, polyclonal activation does occur, but is restricted to the CD5' B cell subset . Moreover, most of the antibodies produced by CD5' B cells are polyreactive and low affinity, similar to those produced by CD5' B cells from normal individuals . At variance with this polyclonal activation model are the recent reports by Shlomchik et al. (29, 30) , suggesting that in MLR/Ipr autoimmune mice, a nonrandom antigen-driven clonal selection is operative in generating autoantibodies to IgG Fc fragment and ssDNA . The demonstration in the present study that RFs produced by some of the CD5'' B cells from RA patients are monoreactive and high affinity, would fit with an antigen-driven clonal selection model (31) . If this were the case, one would predict that the V,, and V,, gene segments of the monoreactive high affinity antibodies would harbor many more somatic mutations than the V. and V,, gene segments coding for the polyreactive low affinity antibodies, which appear to be very close to unmutated "germline" genes (20, 32, and Sanz, et al., manuscript submitted for publication) . Sequencing the genes of both the monoreactive high affinity and polyreactive low affinity RFs in RA patients, which is now in progress, should help resolve this issue.
It has been suggested that the number of the CD5' B cells in the circulation of individuals with RA, may be influenced more by the genetic background than by the expression or activity ofthe disease (33) . A scenario that might relate these various observations is that individuals who have high numbers of proliferating CD5' B cells may be at the greater risk of ultimately developing RA. A high number of proliferating CD5' B cells would increase the likelihood of occasional cells undergoing somatic mutations (34) and producing monoreactive high affinity RFs (35) . These antibodies may be more important in the pathogenesis of RA than polyreactive low affinity antibodies. Along these lines, no direct correlation has been found, thus far, between the titer of RF in the serum of RA patients and the number of circulating CD5' B cells (unpublished data) . Long-term longitudinal studies on the number of CD5' B cells, their state of activation, and the affinity constants of the RFs they produce would be particularly useful in evaluating the role of CD5' B cells in the pathogenesis of different stages of RA.
Summary
In patients with rheumatoid arthritis (RA), circulating CD5' B lymphocytes, but not CD5" B lymphocytes, are increased in number and size, exist in an activated state, spontaneously proliferate, and secrete Ig that binds to the Fc fragment of IgG . By constructing continuous mAb-secreting cell lines from CD5+ B lymphocytes, the properties and dissociation constants (Kd) of these antibodies were determined . Two types ofrheumatoid factors (RFs) with discrete reactivities were produced . The first type is polyreactive and binds with relatively low affinity (Kd, 10" 5 mol/liter) to the Fc fragment ofIgG . These antibodies are similar to those produced by CD5' B cells from healthy subjects. The second type of RF is monoreactive and binds with higher affinity (Kd, 10' mol/liter) to the Fc fragment of IgG . These latter autoantibodies are produced by CD5' B cells of RA patients, but not healthy subjects. Long-term longitudinal studies are needed to determine the role of these two types of RFs in the pathogenesis of RA.
